Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patientsFabio Morandi, Vito Pistoia, Isabella Levreri et al.|Cancer Immunology Immunotherapy|2011Cited by 22